Definitive Healthcare Corp. (NASDAQ:DH) Receives $5.35 Average PT from Analysts

Definitive Healthcare Corp. (NASDAQ:DH) has been assigned an average recommendation of “Hold” from the twelve analysts that are currently covering the stock, MarketBeat reports. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating on the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $5.35.

A number of research analysts have weighed in on DH shares. Needham & Company LLC restated a “hold” rating on shares of Definitive Healthcare in a research note on Thursday, January 16th. Barclays decreased their price target on Definitive Healthcare from $4.00 to $3.00 and set an “underweight” rating for the company in a research note on Monday, March 3rd. Stephens started coverage on Definitive Healthcare in a research note on Friday, December 20th. They issued an “equal weight” rating and a $5.00 price target for the company. Finally, The Goldman Sachs Group decreased their price target on Definitive Healthcare from $4.50 to $3.00 and set a “neutral” rating for the company in a research note on Tuesday, March 4th.

Institutional Trading of Definitive Healthcare

Several hedge funds have recently added to or reduced their stakes in the company. Nisa Investment Advisors LLC increased its stake in Definitive Healthcare by 3,652.7% during the 4th quarter. Nisa Investment Advisors LLC now owns 6,980 shares of the company’s stock worth $29,000 after acquiring an additional 6,794 shares during the period. Bayesian Capital Management LP bought a new position in Definitive Healthcare during the 4th quarter worth $41,000. Point72 DIFC Ltd increased its stake in Definitive Healthcare by 759.9% during the 3rd quarter. Point72 DIFC Ltd now owns 9,296 shares of the company’s stock worth $42,000 after acquiring an additional 8,215 shares during the period. Ieq Capital LLC bought a new position in Definitive Healthcare during the 4th quarter worth $51,000. Finally, KLP Kapitalforvaltning AS bought a new position in Definitive Healthcare during the 4th quarter worth $54,000. 98.67% of the stock is owned by institutional investors and hedge funds.

Definitive Healthcare Price Performance

NASDAQ:DH opened at $2.59 on Friday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49. The company has a market cap of $292.44 million, a PE ratio of -0.84, a PEG ratio of 4.06 and a beta of 1.51. Definitive Healthcare has a 52-week low of $2.55 and a 52-week high of $8.35. The stock has a 50-day simple moving average of $4.34 and a 200 day simple moving average of $4.37.

Definitive Healthcare (NASDAQ:DH) last posted its quarterly earnings data on Thursday, February 27th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.04). The firm had revenue of $62.29 million for the quarter, compared to the consensus estimate of $60.60 million. Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. On average, sell-side analysts expect that Definitive Healthcare will post 0.16 EPS for the current fiscal year.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.